BVB
ActiveSummary
BVB has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.4m and a net result of €467,083. Equity has been growing by about 21% per year since 2018. Its solvency ranks better than 84% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 05-01-2018 Normal situation
- Activity
- General medical practice NACE 86210
- Joint committee
- 330.04 Paritair Comité voor de gezondheidsinrichtingen en -diensten · annual accounts 2025
- Establishment unit
- 2.271.580.246 8530 Harelbeke, since 05-01-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 30-12-2025
Board and ownership
Board
- Beerlandt Inge EstellaDirector · since 05-01-2018
- Van Belle Jan Yvonne AlbertDirector · since 05-01-2018
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2025
- Gross margin
- €680,395
- ▲ 7.3%
- Turnover
- ≈ €1.1m
- estimated
- Profit
- €467,083
- ▲ 6.2%
- Equity
- €1.4m
- ▲ 27.4%
- Total assets
- €1.6m
- ▲ 20.4%
Score breakdownraises risk2 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 11.54, cash €325,862Figures for financial year 2025 (filed on 30-07-2026)Show the evidence
Checked score
Score 2025
97
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 72% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency
100=
equity 90.1% of total assets
Liquidity
75+16
short-term debt 7.1% · cash 20.3%
Profitability
100=
return on assets 29.1%
Bankruptcy probability within 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025
08-2025: 0.2%▲ +0.1 percentage points vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.4%▲ +0.2 percentage points vs 09-2025
11-2025: 0.4%● unchanged vs 10-2025highest value
12-2025: 0.1%▼ -0.3 percentage points vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €140,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 11.54 (7.42 in 2024), above the usual 1.5. Short-term debt is 7.1% and cash 20.3% of total assets. 9.9% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 57% on liquidity, 80% on profitability and 70% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
1 day early
2024
92 days late
2023
69 days late
2022
71 days late
2021
29 days late
2020
27 days late
2019
31 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 45 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 October (4 of the last 5 accounts filed within 41 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 30-07-2026 at the NBB all 8 filings
Turnover
≈ €1.1m
Estimated: probably between €940,000 and €1.3m
Total assets
€1.6m▲ 20.4%
2024 · €1.3m
Net result
€467,083▲ 6.2%
2024 · €439,936
Working capital
€1.2m▲ 28.0%
2024 · €945,155
In the rankings
#3 company by equity in Harelbeke, Health and social work sector#4 company by total assets in Harelbeke, Health and social work sector
Multi-year overview
2018 to 2025, 8 financial yearsOperating result
€614,849
▲ 6.5%
2025
20182025
Net result
€467,083
▲ 6.2%
2025
highest quarter of the sector
20182025
Equity
€1.4m
▲ 27.4%
2025
highest quarter of the sector
20182025
Total assets
€1.6m
▲ 20.4%
2025
highest quarter of the sector
20182025
Debt
€159,860
▼ 19.7%
2025
20182025
Working capital
€1.2m
▲ 28.0%
2025
highest quarter of the sector
20182025
Solvency
90.1%
▲ 5.0pp
2025
highest quarter of the sector
20182025
Current ratio
11.54
▲ 4.11
2025
highest quarter of the sector
20182025
Return on assets (ROA)
29.1%
▼ 3.9pp
2025
middle half of the sector
20182025
Staff (FTE)
0
2025
20182025
Every figure per financial year
Every figure with its change against the financial year before
favourable
unfavourable
Line20182019202020212022202320242025
Operating result€0.2m-€0.3m▲ 26.9%€0.5m▲ 48.4%€0.4m▼ 2.8%€0.4m▼ 15.6%€0.5m▲ 40.1%€0.6m▲ 9.6%€0.6m▲ 6.5%
Net result€0.2m-€0.2m▲ 31.2%€0.3mabove the sector's middle half▲ 51.3%€0.3mabove the sector's middle half▲ 5.6%€0.3mabove the sector's middle half▼ 15.2%€0.4mabove the sector's middle half▲ 43.2%€0.4mabove the sector's middle half▲ 9.5%€0.5mabove the sector's middle half▲ 6.2%
Equity€0.2m-€0.4m▲ 117%€0.7mabove the sector's middle half▲ 81.7%€0.7mabove the sector's middle half=€1.0mwithin the sector's middle half▲ 40.3%€1.4mwithin the sector's middle half▲ 41.1%€1.1mabove the sector's middle half▼ 17.6%€1.4mabove the sector's middle half▲ 27.4%
Total assets€0.9m-€1.1m▲ 20.4%€1.2mabove the sector's middle half▲ 3.6%€1.4mabove the sector's middle half▲ 19.3%€1.3mwithin the sector's middle half▼ 6.2%€1.6mwithin the sector's middle half▲ 25.6%€1.3mabove the sector's middle half▼ 18.2%€1.6mabove the sector's middle half▲ 20.4%
Debt€0.8m-€0.7m▼ 2.3%€0.5m▼ 37.0%€0.7m▲ 48.3%€0.3m▼ 53.1%€0.3m▼ 21.4%€0.2m▼ 21.7%€0.2m▼ 19.7%
Working capital-€0.3m--€0.04m▲ 86.0%€0.4mabove the sector's middle half€0.5mabove the sector's middle half▲ 41.7%€0.9mabove the sector's middle half▲ 76.5%€1.2mabove the sector's middle half▲ 30.1%€0.9mabove the sector's middle half▼ 19.9%€1.2mabove the sector's middle half▲ 28.0%
Solvency18.9%-34.2%▲ 15.3pp60.0%within the sector's middle half▲ 25.8pp50.3%within the sector's middle half▼ 9.7pp75.1%within the sector's middle half▲ 24.9pp84.4%above the sector's middle half▲ 9.3pp85.1%within the sector's middle half▲ 0.7pp90.1%above the sector's middle half▲ 5.0pp
Current ratio0.52-0.93▲ 0.411.98within the sector's middle half▲ 1.041.85within the sector's middle half▼ 0.134.58within the sector's middle half▲ 2.737.00above the sector's middle half▲ 2.427.42above the sector's middle half▲ 0.4211.54above the sector's middle half▲ 4.11
Return on assets (ROA)17.0%-18.5%▲ 1.5pp27.0%above the sector's middle half▲ 8.5pp23.9%within the sector's middle half▼ 3.1pp21.6%above the sector's middle half▼ 2.3pp24.6%above the sector's middle half▲ 3.0pp32.9%within the sector's middle half▲ 8.3pp29.1%within the sector's middle half▼ 3.9pp
Staff (FTE)2.1-2.3▲ 9.5%0.2below the sector's middle half▼ 91.3%0.1▼ 50.0%0
above
within
below
The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
The operating result for 2025 is 7% higher than in 2024 and the highest since 2021. It is the third rise in a row, after the fall in 2022.
Turnover and EBIT margin are not published. The abbreviated or micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.6m
Fixed assets
€282,902 ▲ 16.3%
Current assets
€1.3m ▲ 21.3%
Equity and liabilities €1.6m
Equity
€1.4m ▲ 27.4%
Debt
€159,860 ▼ 19.7%
Debt's share of the balance-sheet total falls from 14.9% to 9.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€678,865▲
2024 · €632,905
Cash flow
€531,099▲
2024 · €495,747
Debt to equity
0.11▼
2024 · 0.18
ROE
32.3%▼
2024 · 38.7%
Interest coverage
62.33▲
2024 · 42.54
Debt ≤ 1 year
€114,799▼
2024 · €147,134
Debt > 1 year
€30,322▼
2024 · €44,336
Income taxes
€149,052▼
2024 · €154,661
Staff costs
€1,138▲
2024 · €390
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Staff
| Item | 31-12-2021 | 31-12-2025 |
|---|---|---|
| Average over the year, in full-time equivalents | 0.1 | 0 |
| Joined | 1 | 2 |
| Left | 1 | 2 |
Source: social balance sheet in the 2021 to 2025 annual accounts
Investments
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Tangible fixed assets | €6,137 | €56,437 | €154,504 | €47,073 | €103,592 |
| Depreciation and write-downs of the year | €168,621 | €174,788 | €38,713 | €55,812 | €64,016 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Annual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | €6,418 | - | €27,792 | €0 | ▼ 100% |
| Remuneration, social security and pensions62 | - | - | - | €1,979 | €799 | €1,358 | €390 | €1,138 | ▲ 192% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €147,161 | €162,584 | €164,067 | €168,621 | €174,788 | €38,713 | €55,812 | €64,016 | ▲ 14.7% |
| Other operating charges640/8 | - | - | - | €5,274 | €5,114 | €1,294 | €560 | €392 | ▼ 30.1% |
| Gross operating margin9900 | €477,714 | €570,777 | €637,191 | €621,084 | €556,639 | €567,994 | €633,856 | €680,395 | ▲ 7.3% |
| Operating profit (loss)9901 | €243,074 | €308,562 | €457,985 | €445,210 | €375,938 | €526,628 | €577,094 | €614,849 | ▲ 6.5% |
| Financial income75/76B | - | - | - | €24 | €1,386 | €13,642 | €32,381 | €12,178 | ▼ 62.4% |
| Recurring financial income75 | €7 | €0 | €14 | €24 | €1,386 | €13,642 | €32,381 | €12,178 | ▼ 62.4% |
| Financial charges65/66B | - | - | - | €8,749 | €7,535 | €8,324 | €14,878 | €10,892 | ▼ 26.8% |
| Recurring financial charges65 | €9,490 | €1,688 | €7,069 | €8,749 | €7,535 | €8,324 | €14,878 | €10,892 | ▼ 26.8% |
| Profit (loss) for the period before taxes9903 | €233,591 | €306,874 | €450,931 | €436,486 | €369,789 | €531,946 | €594,596 | €616,135 | ▲ 3.6% |
| Income taxes67/77 | €75,821 | €99,908 | €137,778 | €105,796 | €89,396 | €130,346 | €154,661 | €149,052 | ▼ 3.6% |
| Profit (loss) for the period9904 | €157,770 | €206,967 | €313,153 | €330,690 | €280,393 | €401,600 | €439,936 | €467,083 | ▲ 6.2% |
| Profit (loss) for the period to be appropriated9905 | €157,770 | €206,967 | €313,153 | €330,690 | €280,393 | €401,600 | €439,936 | €467,083 | ▲ 6.2% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €0.9m | €1.1m | €1.2m | €1.4m | €1.3m | €1.6m | €1.3m | €1.6m | ▲ 20.4% |
| Fixed assets21/28 | €0.6m | €0.5m | €0.4m | €0.3m | €0.1m | €0.3m | €0.2m | €0.3m | ▲ 16.3% |
| Intangible fixed assets21 | €0.5m | €0.4m | €0.3m | €0.1m | - | - | - | - | - |
| Tangible fixed assets22/27 | €0.08m | €0.1m | €0.2m | €0.1m | €0.1m | €0.3m | €0.2m | €0.3m | ▲ 16.3% |
| Land and buildings22 | - | - | - | €0.1m | €0.08m | €0.1m | €0.1m | €0.2m | ▲ 30.9% |
| Plant, machinery and equipment23 | - | - | - | €0.01m | €0.006m | €0.003m | €0.02m | €0.02m | ▲ 16.8% |
| Furniture and vehicles24 | - | - | - | €0.02m | €0.06m | €0.2m | €0.1m | €0.1m | ▲ 0.9% |
| Current assets29/58 | €0.3m | €0.6m | €0.7m | €1.1m | €1.2m | €1.4m | €1.1m | €1.3m | ▲ 21.3% |
| Amounts receivable within one year40/41 | €0.1m | €0.2m | €0.04m | €0.02m | €0.04m | €0.04m | €0.008m | €0.2m | ▲ 22× |
| Trade receivables40 | - | - | - | €0.001m | €0.001m | €0.008m | €0.008m | €0.008m | = |
| Other amounts receivable41 | - | - | - | €0.02m | €0.04m | €0.04m | €0 | €0.2m | - |
| Current investments50/53 | - | - | - | - | - | €1.0m | €0.9m | €0.8m | ▼ 16.0% |
| Cash at bank and in hand54/58 | €0.1m | €0.3m | €0.6m | €1.0m | €1.1m | €0.2m | €0.1m | €0.3m | ▲ 205% |
| Deferred charges and accrued income490/1 | - | - | - | €0.06m | €0.04m | €0.05m | €0.04m | €0.03m | ▼ 16.6% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €0.9m | €1.1m | €1.2m | €1.4m | €1.3m | €1.6m | €1.3m | €1.6m | ▲ 20.4% |
| Equity10/15 | €0.2m | €0.4m | €0.7m | €0.7m | €1.0m | €1.4m | €1.1m | €1.4m | ▲ 27.4% |
| Contributions10/11 | €0.02m | €0.02m | - | €0.02m | €0.02m | €0.02m | €0.02m | €0.02m | = |
| Reserves13 | €0.2m | €0.4m | €0.7m | €0.7m | €0.7m | €0.7m | €0.7m | €0.5m | ▼ 23.0% |
| Non-distributable reserves130/1 | - | - | - | €0.002m | €0.002m | €0.002m | €0 | - | - |
| Reserves not available under the articles1311 | - | - | - | €0.002m | €0.002m | €0.002m | €0 | - | - |
| Distributable reserves133 | - | - | - | €0.7m | €0.7m | €0.7m | €0.7m | €0.5m | ▼ 23.0% |
| Profit (loss) carried forward14 | - | - | - | - | €0.3m | €0.7m | €0.4m | €0.9m | ▲ 106% |
| Amounts payable17/49 | €0.8m | €0.7m | €0.5m | €0.7m | €0.3m | €0.3m | €0.2m | €0.2m | ▼ 19.7% |
| Amounts payable after more than one year17 | €0.1m | €0.1m | €0.09m | €0.08m | €0.07m | €0.06m | €0.04m | €0.03m | ▼ 31.6% |
| Financial debts170/4 | - | - | - | €0.08m | €0.07m | €0.06m | €0.04m | €0.03m | ▼ 31.6% |
| Amounts payable within one year42/48 | €0.6m | €0.6m | €0.4m | €0.6m | €0.3m | €0.2m | €0.1m | €0.1m | ▼ 22.0% |
| Current portion of amounts payable after more than one year42 | - | - | - | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | ▲ 5.4% |
| Financial debts43 | - | - | - | €0.01m | - | €0.04m | €0 | - | - |
| Credit institutions430/8 | - | - | - | €0.01m | - | €0.04m | €0 | - | - |
| Trade debts44 | - | €0.008m | €0.02m | €0.002m | €0.002m | €0.02m | €0.007m | €0.01m | ▲ 42.1% |
| Suppliers440/4 | - | - | - | €0.002m | €0.002m | €0.02m | €0.007m | €0.01m | ▲ 42.1% |
| Taxes, remuneration and social security45 | - | - | - | - | - | €0.005m | €0.02m | €0.001m | ▼ 96.6% |
| Taxes450/3 | - | - | - | - | - | €0.005m | €0.02m | €0.001m | ▼ 96.6% |
| Other amounts payable47/48 | - | - | - | €0.6m | €0.2m | €0.1m | €0.1m | €0.09m | ▼ 14.0% |
| Accrued charges and deferred income492/3 | - | - | - | - | - | - | €0.008m | €0.01m | ▲ 90.9% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €157,770 | €206,967 | €313,153 | €330,690 | €280,393 | €401,600 | €439,936 | €467,083 | ▲ 6.2% |
| + Depreciation and write-downs630 | €147,161 | €162,584 | €164,067 | €168,621 | €174,788 | €38,713 | €55,812 | €64,016 | ▲ 14.7% |
| Operating cash flow (approximation) | €304,932 | €369,551 | €477,220 | €499,311 | €455,181 | €440,313 | €495,747 | €531,099 | ▲ 7.1% |
| Investment in fixed assets (approximation) | - | -€96,774 | -€44,361 | -€6,137 | -€50,437 | -€154,504 | -€42,690 | -€103,592 | ▼ 143% |
| Change in cash | - | €163,009 | €275,544 | €467,873 | €44,726 | -€839,876 | -€137,529 | €219,125 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 6,782 companies had the same profile as BVB has now. Two years later, 96.7% were still going and 0.6% had gone bankrupt.
- Small
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
96.7%
was still going
2.7%
stopped otherwise
0.6%
went bankrupt
That fits the bankruptcy probability of BVB itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,782 companies, not a prediction for BVB. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Filings with the National Bank (8)
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 30-07-2026 | 2026-00355128 | |
| 31-12-2024 | micro format | 31-10-2025 | 2025-00562479 | |
| 31-12-2023 | abbreviated format | 08-10-2024 | 2024-00505537 | |
| 31-12-2022 | abbreviated format | 10-10-2023 | 2023-00484210 | |
| 31-12-2021 | micro format | 29-08-2022 | 2022-20333115 | |
| 31-12-2020 | micro format | 27-08-2021 | 2021-58900568 | |
| 31-12-2019 | abbreviated format | 31-08-2020 | 2020-49500532 | |
| 31-12-2018 | abbreviated format | 30-08-2019 | 2019-58100277 |
Board & ownership
Directors
Directors
2 directors, last change in 2023
Beerlandt Inge Estella
Current
Statutory director · since 05-01-2018 · earlier statutory manager, until 07-06-2023 · listed in the 2025 annual accounts, filed on 30-07-2026
Van Belle Jan Yvonne Albert
Current
Statutory director · since 05-01-2018 · earlier statutory manager, until 07-06-2023 · listed in the 2025 annual accounts, filed on 30-07-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“c. enkel een arts-aandeelhouder tot statutair bestuurder kan worden benoemd en voor niet-medische aangelegenheden ook een niet-arts kan…”
deed of 07-06-2023Owners and capital
Capital transactions
Capital over time
- 07-06-2023 Converted to unavailable equity
Mandate history
2 people, 2 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Beerlandt Inge Estella |
|
| Van Belle Jan Yvonne Albert |
|
Network & group
BVB shares no director with another company.
Companies at the same address
3 other companiesConnections & network
2 current directorsThe network starts from the directors of BVB. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
30-07
micro format · 1 day before the deadline
2025
31-12
Financial
Highest result from 2018 to 2025net €467,083 ▲6.2%
The operating result of €614,849 and the net result of €467,083 are both a record.
31-10
micro format · 92 days late
2024
08-10
abbreviated format · 69 days late
2023
31-12
Financial
Equity above €1mequity €1.4m ▲41.1%
With a profit in every financial year since 2018, equity grows to €1.4m.
10-10
abbreviated format · 71 days late
07-06
Gazette deed
2 directors appointed, 2 directors resigning, 2 reappointedChanges of role: Van Belle Jan Yvonne Albert (statutory director) and Beerlandt Inge Estella (statutory director) · Reappointments: Van Belle Jan Yvonne Albert (statutory director) and Beerlandt Inge Estella (statutory director) · Power of attorney16 points ▸
Gazette deed
2 directors appointed, 2 directors resigning, 2 reappointed
Changes of role: Van Belle Jan Yvonne Albert (statutory director) and Beerlandt Inge Estella (statutory director) · Reappointments: Van Belle Jan Yvonne Albert (statutory director) and Beerlandt Inge Estella (statutory director) · Power of attorney16 points ▸
- Director appointment, Van Belle Jan Yvonne Albert (statutory director)
- Director appointment, Beerlandt Inge Estella (statutory director)
- Power of attorney
- Power of attorney, STEVEN VANDEN DAELEN (ondergetekende notaris)
- General meeting, 24-05-2023
- Amendment of the articles, mentioned 3 times in the deed
- Legal form clause, “besloten vennootschap” (deed in Dutch)
- Registered office clause, “Vlaams Gewest, Stasegemsestraat 34,8530 Harelbeke” (deed in Dutch)
- Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Reserve release, “opheffing, middelen beschikbaar voor uitkering” (deed in Dutch)
- Director resignation, Van Belle Jan Yvonne Albert (statutory manager)
- Director resignation, Beerlandt Inge Estella (statutory manager)
- The act holds 4 more points.
2022
31-12
Financial
Liquidity more than doubledcurrent ratio 4.58
The current ratio rises from 1.85 to 4.58. Short-term debt falls from €606,718 to €253,088.
29-08
micro format · 29 days late
2021
27-08
micro format · 27 days late
2020
31-12
Financial
Liquidity more than doubledcurrent ratio 1.98
The current ratio rises from 0.93 to 1.98. Short-term debt falls from €613,607 to €370,976.
31-12
Financial
Equity above €500,000equity €696,490 ▲81.7%
With a profit in every financial year since 2018, equity grows to €696,490.
Show earlier events
31-08
abbreviated format · 31 days late
2019
31-12
Financial
Equity above €200,000equity €383,337 ▲117%
With a profit in every financial year since 2018, equity grows to €383,337.
30-08
abbreviated format · 30 days late
2018
09-01
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordName
BVB in Dutch
Enterprise number
0687.599.940
LEI code
9845008A581CF54KDE78
live in the LEI register
Legal form
Private limited company
Status
Active, normale toestand
Founded
05-01-2018
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 07-06-2023 (in Dutch)Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest”
deed of 07-06-2023 (in Dutch)Registered office and establishments
Registered office
Stasegemsestraat 34, 8530 Harelbeke, Belgium
Establishment unit
Huisartsen Beerlandt - van Belle, Stasegemsestraat 34, 8530 Harelbeke since 05-01-2018 · unit number 2.271.580.246
Activities
NACEBEL 2025VAT activities
86210
General medical practice main activity
Social security (RSZ) activities
86210
General medical practice main activity
Codes under NACEBEL 2008
VAT activities
86210
General medical practice main activity
Social security (RSZ) activities
86210
General medical practice main activity
Joint committee
330.04 Paritair Comité voor de gezondheidsinrichtingen en -diensten annual accounts 2025
PurposeThe purpose describes the activities the company may carry out under its articles.
deed of 07-06-2023 (in Dutch)
“In binnen-en buitenland,voor eigen rekening of voor rekening van derden de uitoefening van de geneeskunde door de arts(en)-aandeelhouder(s)…”
18 activities
- In binnen-en buitenland,voor eigen rekening of voor rekening van derden de uitoefening van de geneeskunde door de arts(en)-aandeelhouder(s) in de meest ruime zin,en specifiek dan als huisarts,rekening houdend met de Medische Plichtenleer.
- Alle inkomsten voortvloeiend uit de ingebrachte medische activiteit worden rechtstreeks geïnd voor en door de vennootschap,zoals alle uit de medische activiteit voortvloeiende uitgaven door de vennootschap worden vereffend.
- Alle inkomsten voortvloeiend uit de ingebrachte medische activiteit worden geïnd voor en door de vennootschap,zoals alle uit de medische activiteit voortvloeiende uitgaven door de vennootschap worden vereffend.
- De inrichting van algemene diensten en een medisch secretariaat in het bijzonder die nuttig of nodig zijn voor de uitoefening van voormelde activiteit
- De aankoop,de huur en/of leasing van alle medische apparatuur en begeleidende accommodatie inclusief gebouwen,kortom van een volledige materiële infrastructuur om deze ter beschikking te stellen van de arts(en)-aandeelhouder(s)
- Het scheppen van de mogelijkheden om de arts(en)-aandeelhouder(s) toe te laten zich verder te bekwamen in voormelde medische discipline,dit teneinde een kwalitatief hoogstaande praktijkuitoefening mogelijk te maken
- De verstrekking van informatie en/of onderricht inzake voormelde medische discipline en dit in de breedste betekenis van het woord,zonder dat dit de vorm van een aanvullende commerciële activiteit mag aannemen
- De organisatie van symposia,cursussen,studiereizen en lessencycli in verband met de voornoemde specialiteit
- Alle nodige en nuttige werkzaamheden en rechtshandelingen stellen voor de ontwikkeling en de beoefening van erkende en experimentele verbale en nonverbale therapieën
- Bij gelegenheid het organiseren van vormingen en nascholingen in medische zaken,het schrijven en uitgeven van medische artikels en werken,het optreden als stagemeester
- De vennootschap mag alle financiële activiteiten en alle roerende en onroerende handelingen verrichten die van die aard zijn de verwezenlijking van haar voorwerp te bevorderen
- De vennootschap kan zonder afbreuk te doen aan de medische plichtenleer onder het normale beheer als een redelijk en voorzichtig persoon een bestemming geven aan haar gereserveerde winsten van welke aard ook
- De vennootschap kan bijgevolg alle investeringen en beleggingen uitvoeren zoals onder meer de aankoop,de verhuring en de oprichting van gebouwen,inbegrepen deze gedaan als alternatieve beloningsvorm voor haar bestuurder(s),zonder evenwel het burgerlijk karakter van de vennootschap aan te tasten
- De vennootschap mag deze roerende en onroerende goederen beheren als een redelijk en voorzichtig persoon,zonder dat dit de vorm van een aanvullende commerciële activiteit aanneemt
- De belegging of investering van haar middelen mag gefinancierd worden door leningen
- De vennootschap mag deelnemen in alle ondernemingen die een gelijkaardig voorwerp nastreven
- De vennootschap kan deelnemen in kostenassociaties of middelenvennootschappen van artsen
- De vennootschap kan tevens lid zijn van een vereniging zonder winstgevend doel van de artsen
Invoicing and payment
VAT number
BE 0687.599.940
Financial year and general meeting
Accounts at the NBBFinancial year end
31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Tuesday of May at 10:00
deed of 07-06-2023 (in Dutch)Sites & property
Location
Buildings and parcels at the address
Ground area
392 m²
Building footprint
224 m²
Building volume
1,496 m³
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 34013A1286/00H002 | Flanders | 392 m² | 1 · 224 m² | 9.8 m · 2 |